Skip to main content
. 2020 May 12;111(6):1969–1978. doi: 10.1111/cas.14421

Table 1.

Association of clinicopathological features and programmed death ligand‐1 (PD‐L1) expression, CD8 expression, and hot tumor immune status in 41 esophageal squamous cell carcinoma (ESCC) patients

Factor PD‐L1 expression P value CD8 expression P value Tumor immune status P value
Low (n = 19) High (n = 22) Low (n = 27) High (n = 14) Hot tumor (high PD‐L1/high CD8, n = 13) Others (n = 28)
Age (y)
Mean ± SD 67.7 ± 7.1 65.6 ± 6.3 .32 67.0 ± 6.8 65.9 ± 6.7 .64 65.4 ± 6.6 67.2 ± 6.7 .43
Sex
Male 15 21 .11 23 13 .48 12 24 .55
Female 4 1 4 1 1 4
Tumor invasion
T1, T2 15 10 .028 17 8 .717 7 18 .524
T3, T4 4 12 10 6 6 10
N factor
Absent 9 5 .097 9 5 .879 4 10 .756
Present 10 17 18 9 9 18
Lymphatic invasion
Absent 7 2 .032 6 3 .954 2 7 .489
Present 12 20 21 11 11 21
Venous invasion
Absent 9 3 .018 9 3 .427 3 9 .553
Present 10 19 18 11 10 19
Stage
Stage I, II 13 8 .041 15 6 .441 5 16 .266
Stage III, IV 6 14 12 8 8 12
PD‐L1 expression
Low 18 1 <.001
High 9 13
CD8 positive lymphocytes
Low 18 9 <.001
High 1 13
GLUT1
Low 11 2 <.001 11 2 .084 1 12 .024
High 8 20 16 12 12 16
LAT1
Low 15 8 .006 16 7 .571 6 17 .382
High 4 14 11 7 7 11
Ki‐67 labeling index
Mean ± SD 36.8 ± 19.2 52.4 ± 17.6 .009 39.1 ± 18.2 56.7 ± 17.8 .005 56.1 ± 18.3 40.1 ± 18.6 .014
CD34 positive vessels counts
Mean ± SD 13.9 ± 5.3 22.1 ± 5.9 <.001 17.0 ± 7.0 21.0 ± 6.0 .075 20.9 ± 6.2 17.1 ± 7.0 .103